Bioquell Industry News | Infection Control & Decontamination

Bioquell Micro Sites

Bioquell Norway Site

Industry News

C.diff superbug has been catalyst for healthcare change

Published on 1st May 2013

The Clostridium difficile (C.difficile) superbug has been a real catalyst for change in US hospitals, according to one healthcare professional.

Drug resistant malaria parasite discovered

Published on 30th April 2013

Scientists have identified a new drug resistant strain of the parasite that causes malaria.

Three new life science centres to be built in Scotland

Published on 24th April 2013

Three new life science centres are to be built in Scotland, funded partly by a £30 million government grant.

Life sciences campus plans awaiting approval from council

Published on 22nd April 2013

Plans to create a new life sciences campus in Birmingham rest upon the local council giving its approval for the Harvest Partnership to secure the site, insidermedia.com reports.

FDA should have acted earlier against NECC pharmacy, claims report

Published on 17th April 2013

One of the deadliest medication-related outbreaks in US history, linked to the contamination of medicine, could have been prevented as the Massachusetts pharmacy responsible for a deadly meningitis outbreak should have been closed before the crisis.

Cleanroom space tipped to increase in 2013

Published on 15th April 2013

Cleanroom space has been tipped to increase by five per cent across the world this year.

FDA find compound pharmacy safety failures in the US

Published on 5th April 2013

Compounding pharmacies in the US are falling short of federal safety and sanitation requirements, according to discoveries from the Food and Drug Administration (FDA).

Life sciences companies to save billions in tax from this week

Published on 2nd April 2013

Two new tax breaks, tipped to dramatically accelerate the growth of Britain's life sciences industry, have been officially introduced.

FDA approves new Multiple Sclerosis drug, Tecfidera

Published on 28th March 2013

Biogen Idec Inc.'s latest drug, Tecfidera, has been approved by the US Food and Drug Administration (FDA) for treatment of Multiple Sclerosis (MS).

Cardiff life sciences hub will launch this year

Published on 22nd March 2013

A new £100 million life sciences hub will be set up in Cardiff by the end of the year, it has been confirmed.

1
2
3
4
5
6
7
Next
Last
Page 1 of 7

Contact

United Kingdom flag icon Change location
Bioquell UK Ltd
52 Royce Close
West Portway
Andover
Hampshire SP10 3TS

Technical support
T: +44 (0)1264 835 800